The Claim
In middle-aged adults, a higher plasma omega-6/omega-3 fatty acid and oxylipin ratio is associated with elevated insulin resistance (HOMA index), increased triglycerides, higher LDL cholesterol, and reduced HDL cholesterol, indicating a cardiometabolic risk profile characterized by impaired glucose metabolism and dyslipidemia.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In middle-aged adults, a higher ratio of omega-6 to omega-3 fatty acids and related oxylipins in the blood is linked to higher insulin resistance, higher triglycerides, higher LDL cholesterol, and lower HDL cholesterol, which together define a cardiometabolic risk profile.
See the scientific wording
In middle-aged adults, a higher plasma omega-6/omega-3 fatty acid and oxylipin ratio is associated with elevated insulin resistance (HOMA index), increased triglycerides, higher LDL cholesterol, and reduced HDL cholesterol, indicating a cardiometabolic risk profile characterized by impaired glucose metabolism and dyslipidemia.
When there is too much omega-6 fat compared to omega-3 fat in the blood, the body makes more inflammatory signaling molecules that block insulin from working properly, cause the liver to store more fat, and change cholesterol levels to raise bad cholesterol and lower good cholesterol.
What the research says
1 studyThis study found that people with more omega-6 fats and fewer omega-3 fats in their blood tend to have higher blood sugar, worse cholesterol, and more fat in their blood—all signs of higher risk for heart disease and diabetes.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.